Alexion Pharmaceuticals Inc $161.56

down 0.00


18/9/2014 04:00 PM  |  NASDAQ : ALXN  
Industries : Drugs / Biotechnology

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
4/10/2013BELL LEONARDCEO-26,700$100.24-1.79%
4/02/2013BELL LEONARDCEO-8,300$99.97-0.55%
4/01/2013BELL LEONARDCEO-35,000$95.00-2.27%
3/08/2013PARVEN ALVIN SDirector-3,115$92.00-29.88%
3/08/2013SQUINTO STEPHEN PEVP, Head of R&D13,750$17.9812.68%
3/08/2013SQUINTO STEPHEN PEVP, Head of R&D6,250$22.905.11%
3/08/2013SQUINTO STEPHEN PEVP, Head of R&D-16,915$91.21-13.17%
3/08/2013SQUINTO STEPHEN PEVP, Head of R&D-3,085$92.17-2.77%
2/04/2013BELL LEONARDCEO-3,900$95.86-0.25%
2/04/2013SQUINTO STEPHEN PEVP, Head of R&D-52$96.49-0.06%
2/04/2013SQUINTO STEPHEN PEVP, Head of R&D-2,520$95.66-2.98%
2/04/2013Hallal DavidEVP, Chief Commercial Officer-985$96.74-1.40%
2/04/2013Hallal DavidEVP, Chief Commercial Officer-1,100$95.68-1.54%
2/04/2013Sinha VikasEVP & CFO-70$96.54-0.02%
2/04/2013Sinha VikasEVP & CFO-1,102$96.17-0.36%
2/04/2013Sinha VikasEVP & CFO-2,311$95.61-0.74%
2/04/2013BELL LEONARDCEO-180$96.22-0.01%
2/04/2013BELL LEONARDCEO-7,800$96.48-0.51%
1/29/2013Hallal DavidEVP. Global Commercial Ops-512$94.32-0.71%
1/29/2013Sinha VikasEVP & CFO-975$94.32-0.31%
1/29/2013BELL LEONARDCEO-2,682$94.32-0.17%
1/29/2013SQUINTO STEPHEN PEVP, Head of R&D-767$94.32-0.90%
1/28/2013SQUINTO STEPHEN PEVP, Head of R&D-715$94.50-0.83%
1/28/2013BELL LEONARDCEO-2,560$94.50-0.17%
1/28/2013Sinha VikasEVP & CFO-1,007$94.50-0.32%
1/28/2013Hallal DavidEVP. Global Commercial Ops-632$94.50-0.87%
1/15/2013BELL LEONARDCEO-34,819$98.58-2.21%
1/15/2013BELL LEONARDCEO-181$99.16-0.01%
1/09/2013BELL LEONARDCEO-27,197$99.96-1.70%
1/02/2013BELL LEONARDCEO-7,803$99.93-0.48%
12/18/2012BELL LEONARDCEO-35,000$95.68-2.13%
12/12/2012Veneman Ann MDirector-4,579$95.00-41.10%
12/10/2012NORBY R DOUGLASDirector15,000$4.9338.79%
12/10/2012NORBY R DOUGLASDirector7,000$10.8413.04%
12/10/2012NORBY R DOUGLASDirector-22,000$93.00-36.26%
11/28/2012BELL LEONARDCEO-13,515$94.96-0.80%
11/28/2012BELL LEONARDCEO-35,000$94.97-2.08%
11/28/2012BELL LEONARDCEO13,515$4.030.80%
11/19/2012PARVEN ALVIN SDirector-1,413$92.16-16.20%
11/19/2012PARVEN ALVIN SDirector-19,281$91.51-68.85%
11/19/2012PARVEN ALVIN SDirector-9,306$90.74-24.94%
11/19/2012PARVEN ALVIN SDirector30,000$10.84410.34%
10/31/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l-12,030$92.18-91.50%
10/31/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l-39,188$91.15-74.88%
10/31/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l-33,546$90.80-39.06%
10/31/2012BELL LEONARDCEO5,315$4.030.32%
10/31/2012BELL LEONARDCEO-5,315$95.00-0.32%
10/31/2012BELL LEONARDCEO-2,667$94.98-0.16%
10/24/2012Hallal DavidSVP. Global Commercial Ops10,500$8.1616.94%
10/01/2012BELL LEONARDCEO-17,770$115.26-1.05%
10/01/2012BELL LEONARDCEO-300$115.92-0.02%
10/01/2012BELL LEONARDCEO18,070$4.031.07%
9/28/2012BELL LEONARDCEO-76,100$111.44-4.35%
9/28/2012BELL LEONARDCEO7,500$5.100.46%
9/28/2012BELL LEONARDCEO32,064$8.181.96%
9/28/2012BELL LEONARDCEO33,000$5.821.97%
9/28/2012BELL LEONARDCEO43,100$4.032.53%
9/28/2012BELL LEONARDCEO9,720$10.290.58%
9/27/2012BELL LEONARDCEO-1,008$114.44-0.06%
9/27/2012BELL LEONARDCEO-34,166$111.96-2.01%
9/27/2012BELL LEONARDCEO-31,826$113.16-1.91%
8/28/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l21,551$42.6625.09%
8/28/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l-21,551$106.37-20.06%
8/27/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l29,734$22.9034.62%
8/27/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l12,198$42.6610.55%
8/27/2012Coissac PatriceSVP & Pres. ALXN Pharma Int'l-41,932$107.05-32.81%
8/24/2012LINK MAXDirector40,000$10.8444.55%
8/24/2012LINK MAXDirector40,000$18.0130.82%
8/23/2012DUBIN THOMAS I HSVP & Chief Legal Officer-24,328$103.09-24.52%
8/23/2012DUBIN THOMAS I HSVP & Chief Legal Officer-9,200$103.87-12.28%
8/14/2012LINK MAXDirector-27,446$104.24-23.41%
8/14/2012LINK MAXDirector-72,227$103.76-38.12%
8/03/2012MADRI JOSEPH ADirector-30,000$107.32-10.84%
8/03/2012MADRI JOSEPH ADirector30,000$4.2612.16%
7/31/2012SQUINTO STEPHEN PEVP, Research & Development-1,015$105.01-1.17%
7/31/2012Sinha VikasSVP & CFO-900$104.94-0.29%
7/31/2012DUBIN THOMAS I HSVP & Chief Legal Officer-680$104.94-0.68%
7/31/2012Hallal DavidSVP. Global Commercial Ops-680$104.99-1.09%
7/31/2012BELL LEONARDCEO-2,470$104.96-0.15%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer28,124$42.6611.74%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer4,000$78.881.49%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer56,250$22.9030.70%
7/27/2012SQUINTO STEPHEN PEVP, Research & Development-38,951$107.75-27.26%
7/27/2012SQUINTO STEPHEN PEVP, Research & Development-19,069$106.93-11.77%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer-6,268$105.76-2.31%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer82,671$17.9882.19%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer-28,200$109.28-21.90%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer-68,632$108.56-34.77%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer-51,303$107.57-20.63%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer-16,642$106.35-6.27%
7/27/2012DUBIN THOMAS I HSVP & Chief Legal Officer-668$106.14-0.66%
7/27/2012SQUINTO STEPHEN PEVP, Research & Development60,626$22.9047.72%
7/27/2012SQUINTO STEPHEN PEVP, Research & Development-25,680$105.86-13.68%
7/27/2012SQUINTO STEPHEN PEVP, Research & Development39,374$17.9844.92%
7/27/2012Hallal DavidSVP. Global Commercial Ops-555$106.14-0.88%
7/27/2012Sinha VikasSVP & CFO-868$106.14-0.28%
7/27/2012Sinha VikasSVP & CFO-17,891$109.37-5.37%
7/27/2012Sinha VikasSVP & CFO30,000$11.929.51%
7/27/2012Sinha VikasSVP & CFO-12,109$108.39-3.51%
7/27/2012Hallal DavidSVP. Global Commercial Ops50,000$17.6579.10%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ALXN), click here.
Trading Center